SEC Form D filing

Biovantix Biotechnology, Inc, 2025-10-17

An SEC Form D private-offering notice from Dover, DE, a $15,000,000 filer-stated offering target in Biotech. Filed 2025-10-17. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Biovantix Biotechnology, Inc Verified via SEC Form D

Biotechnology platform company developing an AI enhanced nanoplatform for biologic drug delivery.

Filed 2025-10-17Filed to raise $15,000,000HQ (as filed) Dover, DESector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status No reported sale
Source linked the Form D on EDGAR↗Named in the filing 3 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source